AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Diaglip M 5mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Cipla Ltd

Salt Composition

Glipizide (5mg) + Metformin (500mg)

Overview Diaglip M 5mg/500mg Tablet

Glimepiride/Metformin 5 mg/500 mg tablets are antidiabetic medications combining two drugs to manage type 2 diabetes in adults. They help regulate blood glucose. These tablets should be taken with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may adjust based on your blood sugar response. Continued use, even with controlled blood sugar, is crucial. Discontinuing without medical guidance can elevate blood glucose, risking kidney complications, vision loss, neuropathy, and limb damage. This medication complements a comprehensive treatment plan involving diet, exercise, and weight management as directed by your doctor. Lifestyle significantly impacts diabetes control. Hypoglycemia (low blood sugar) is a common side effect. Learn to recognize symptoms like sweating, dizziness, headache, and tremors, and know how to treat them. Maintain regular mealtimes and carry a fast-acting glucose source. Alcohol consumption increases hypoglycemia risk and should be limited. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, swelling, blurred vision, bone fractures, and upper respiratory infections. Weight gain is possible. This medication is unsuitable for type 1 diabetes, diabetic ketoacidosis, or severe kidney/liver disease. Inform your doctor of any heart history before commencing treatment. Pregnant or breastfeeding individuals require medical consultation prior to use. Regular blood glucose monitoring, along with blood cell and liver function tests, may be recommended by your physician.

Uses of Diaglip M 5mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Diaglip M 5mg/500mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Diaglip M 5 mg/500 mg tablets with food.

Common Side effects of Diaglip M 5mg/500mg Tablet:

  • Hypoglycemia (low blood glucose level)
  • Diarrhea
  • Headache
  • Upper respiratory tract infection

How to use Diaglip M 5mg/500mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Diaglip M 5 mg/500 mg Tablet whole; do not crush, chew, or fracture it. Administer this medicine with food.

How Diaglip M 5mg/500mg Tablet works:

Glipizide and Metformin, combined as Diaglip M 5 mg/500 mg tablets, offer dual-action diabetes management.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Alcohol consumption while taking Diaglip M 5 mg/500 mg tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Diaglip M 5 mg/500 mg tablets during pregnancy may pose risks. While human research is limited, animal studies indicate potential harm to a developing fetus. A physician will assess the potential benefits against possible risks prior to prescribing. Seek medical advice before taking this medication.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Use of Diaglip M 5 mg/500 mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Diaglip M 5 mg/500 mg tablets cautiously, potentially requiring dosage modification. Consult your physician for guidance. Diaglip M 5 mg/500 mg tablets are contraindicated in patients with severe kidney disease. Regular monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Individuals with liver impairment should use Diaglip M 5 mg/500 mg tablets cautiously. Dosage modification may be necessary. Physician consultation is advised. For those with mild to moderate liver disease, a low initial dose of Diaglip M 5 mg/500 mg tablets is typically recommended; however, its use is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Diaglip M 5mg/500mg Tablet :

Should you forget to take your Diaglip M 5 mg/500 mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Diaglip M 5mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Diaglip M 5mg/500mg Tablet

Diaglip M 5 mg/500 mg tablets combine glipizide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glipizide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Diaglip M 5 mg/500 mg Tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use can result in vitamin B12 deficiency.
Diaglip M 5 mg/500 mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Always keep a readily available source of glucose, such as tablets, honey, or fruit juice, on hand.
Diaglip M 5 mg/500 mg Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-Associated Lactic Acidosis or MALA). While rare, this risk is heightened in patients with kidney disease, the elderly, or those who consume significant amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience any of these, discontinue use and seek immediate medical attention.
Prolonged Diaglip M 5 mg/500 mg Tablet use can lead to vitamin B12 deficiency by hindering its stomach absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness), urinary issues, cognitive changes, and balance problems (ataxia). To mitigate this risk, annual supplemental vitamin B12 intake is recommended by some researchers.
Diaglip M 5 mg/500 mg Tablets are contraindicated in patients with known allergies to any ingredient, those with moderate to severe kidney disease, and those with underlying metabolic acidosis, including diabetic ketoacidosis.
Combining Diaglip M 5 mg/500 mg Tablet with alcohol is unsafe; it can worsen hypoglycemia and raise the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Diaglip M 5mg/500mg Table...
11
MRP 13
16% off